{"id":"W2053296685","doi":"10.2460/ajvr.2005.66.1278","title":"In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in cats with lipopolysaccharide-induced pyrexia","year":2005,"lang":"en","type":"article","venue":"American Journal of Veterinary Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"CATS; Pharmacology; Pharmacokinetics; In vivo; Oral administration; Cyclooxygenase; Bioavailability; Medicine; Potency; Lipopolysaccharide; Dosing; Chemistry; In vitro; Internal medicine; Enzyme; Biology; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002714143,0.0002416986,0.0003720626,0.0001310743,0.0001169284,0.0002428663,0.0001348527,0.0002492903,0.0008106955],"category_scores_gemma":[0.0003774303,0.0001298784,0.0001340027,0.00006571438,0.0002448726,0.0001778031,0.00008877504,0.0003734421,0.0002275843],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004095761,"about_ca_system_score_gemma":0.0002207446,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001197746,"about_ca_topic_score_gemma":0.002184442,"domain_scores_codex":[0.9998815,0.00002630205,0.0000101396,0.00002570581,0.00002854448,0.00002786823],"domain_scores_gemma":[0.9998086,0.00004025654,0.00007672415,0.00001110482,0.00001905055,0.0000442299],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003922995,0.0006011642,0.006103191,0.0002392479,0.0000504565,0.0003024178,0.00008601032,0.0004080864,0.9765359,0.00004320249,0.0001717475,0.01153569],"study_design_scores_gemma":[0.0006066746,0.06403962,0.08355135,0.00004552816,0.0002401884,0.002884884,0.000168368,0.003748021,0.8410792,0.00004206517,0.003571526,0.00002248878],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980268,0.001263064,0.0003316274,0.00003652578,0.000007566401,0.00003056457,0.00007733429,0.00000974365,0.0002168],"genre_scores_gemma":[0.9975379,0.0007846159,0.0009596159,0.00004485453,0.00001102414,0.00003196383,0.000291323,0.00000235363,0.0003362523],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001197746,"threshold_uncertainty_score":0.002971649,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04016947701904237,"score_gpt":0.3669085708167045,"score_spread":0.3267390937976621,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}